MBP-11901 Inhibits Tumor Growth of Hepatocellular Carcinoma through Multitargeted Inhibition of Receptor Tyrosine Kinases

SIMPLE SUMMARY: Although various treatments such as surgery and chemotherapy exist for advanced or unresectable HCC, most patients suffer from intractable diseases, having a poor prognosis. While immunotherapy using immune checkpoint inhibitors was recently proposed for HCC, only a small percentage...

Descripción completa

Detalles Bibliográficos
Autores principales: Park, Hyun Jin, Choi, Garam, Ha, Seongmin, Kim, Yesl, Choi, Min-Jin, Kim, Minsup, Islam, Md. Kamrul, Chang, Yongmin, Kwon, Tae-Jun, Kim, Dongkyu, Jang, Eunbee, Kim, Tae Hwan, Chang, Sha Joung, Kim, Yeoun-Hee
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9030223/
https://www.ncbi.nlm.nih.gov/pubmed/35454900
http://dx.doi.org/10.3390/cancers14081994

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9030223/
https://www.ncbi.nlm.nih.gov/pubmed/35454900
http://dx.doi.org/10.3390/cancers14081994

Ejemplares similares